Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study.

Document Type

Article

Publication Date

11-1-2024

Identifier

DOI: 10.1001/jamacardio.2024.2824; PMCID: PMC11425184

Abstract

IMPORTANCE: The ability to predict sudden cardiac death (SCD) in children and adolescents with hypertrophic cardiomyopathy (HCM) is currently inadequate. Late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) imaging is associated with SCD events in adults with HCM.

OBJECTIVE: To examine the prognostic significance of LGE in patients with HCM who are younger than 21 years.

DESIGN, SETTING, AND PARTICIPANTS: This multicenter, retrospective cohort study was conducted from April 8, 2015, to September 12, 2022, in patients with HCM who were younger than 21 years and had undergone CMR imaging across multiple sites in the US, Europe, and South America. Observers of CMR studies were masked toward outcomes and demographic characteristics.

EXPOSURE: Natural history of HCM.

MAIN OUTCOME AND MEASURES: The primary outcome was SCD and surrogate events, including resuscitated cardiac arrest and appropriate discharges from an implantable defibrillator. Continuous and categorical data are expressed as mean (SD), median (IQR), or number (percentage), respectively. Survivor curves comparing patients with and without LGE were constructed by the Kaplan-Meier method, and likelihood of subsequent clinical events was further evaluated using univariate and multivariable Cox proportional hazards models.

RESULTS: Among 700 patients from 37 international centers, median (IQR) age was 14.8 (11.9-17.4) years, and 518 participants (74.0%) were male. During a median (IQR) [range] follow-up period of 1.9 (0.5-4.1) [0.1-14.8] years, 35 patients (5.0%) experienced SCD or equivalent events. LGE was present in 230 patients (32.9%), which constituted an mean (SD) burden of 5.9% (7.3%) of left ventricular myocardium. The LGE amount was higher in older patients and those with greater left ventricular mass and maximal wall thickness; patients with LGE had lower left ventricular ejection fractions and larger left atrial diameters. The presence and burden of LGE was associated with SCD, even after correcting for existing risk stratification tools. Patients with 10% or more LGE, relative to total myocardium, had a higher risk of SCD (unadjusted hazard ratio [HR], 2.19; 95% CI, 1.59-3.02; P < .001). Furthermore, the addition of LGE burden improved the performance of the HCM Risk-Kids score (before LGE addition: 0.66; 95% CI, 0.58-0.75; after LGE addition: 0.73; 95% CI, 0.66-0.81) and Precision Medicine in Cardiomyopathy score (before LGE addition: 0.68; 95% CI, 0.49-0.77; after LGE addition: 0.73; 95% CI, 0.64-0.82) SCD predictive models.

CONCLUSIONS AND RELEVANCE: In this retrospective cohort study, quantitative LGE was a risk factor for SCD in patients younger than 21 years with HCM and improved risk stratification.

Journal Title

JAMA Cardiol

Volume

9

Issue

11

First Page

1001

Last Page

1008

MeSH Keywords

Humans; Death, Sudden, Cardiac; Cardiomyopathy, Hypertrophic; Male; Female; Adolescent; Retrospective Studies; Magnetic Resonance Imaging, Cine; Child; Myocardium; Cicatrix; Young Adult; Prognosis; Europe; Risk Factors; Gadolinium; Cohort Studies; United States

Keywords

Cardiac Death, Sudden; Cardiomyopathy, Hypertrophic; Retrospective Studies; Magnetic Resonance Imaging, Cine; Myocardium; Cicatrix; Prognosis; Europe; Gadolinium Risk Factors; Cohort Studies; United States

Link to Full Text
Library Record

Share

COinS